
XELTIS BV
Most popular related searches
- Status: Proof-of-concept and preclinical trials completed; First-in-human trial initiation.
- Results: Successful formation of functional, living 20 cm long graft in one-year preclinical study. Improved healing compared to commercially available synthetic grafts ePTFE.